Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SANOFI INDIA   TEVA PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-23
TEVA PHARMA
Dec-13
SANOFI INDIA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs8,2783,479-   
Low Rs5,2403,022-   
Sales per share (Unadj.) Rs1,238.01,996.4-  
Earnings per share (Unadj.) Rs261.8124.7-  
Cash flow per share (Unadj.) Rs279.0286.1-  
Dividends per share (Unadj.) Rs167.00109.18-  
Avg Dividend yield %2.53.4 73.6%  
Book value per share (Unadj.) Rs411.22,217.6-  
Shares outstanding (eoy) m23.03848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.51.6 335.3%   
Avg P/E ratio x25.826.1 99.1%  
P/CF ratio (eoy) x24.211.4 213.2%  
Price / Book Value ratio x16.41.5 1,121.6%  
Dividend payout %63.887.5 72.9%   
Avg Mkt Cap Rs m155,6592,756,220 5.6%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m3,7060-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m28,5111,692,969 1.7%  
Other income Rs m6650-   
Total revenues Rs m29,1761,692,969 1.7%   
Gross profit Rs m8,203463,620 1.8%  
Depreciation Rs m396136,844 0.3%   
Interest Rs m1733,253 0.1%   
Profit before tax Rs m8,455293,523 2.9%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m2,426-3,584 -67.7%   
Profit after tax Rs m6,029105,758 5.7%  
Gross profit margin %28.827.4 105.1%  
Effective tax rate %28.7-1.2 -2,350.2%   
Net profit margin %21.16.2 338.5%  
BALANCE SHEET DATA
Current assets Rs m31,3141,143,425 2.7%   
Current liabilities Rs m25,347997,163 2.5%   
Net working cap to sales %20.98.6 242.2%  
Current ratio x1.21.1 107.7%  
Inventory Days Days15991 174.9%  
Debtors Days Days1796 17.6%  
Net fixed assets Rs m15,714552,961 2.8%   
Share capital Rs m2304,167 5.5%   
"Free" reserves Rs m9,2390-   
Net worth Rs m9,4691,880,567 0.5%   
Long term debt Rs m0865,653 0.0%   
Total assets Rs m47,0283,868,976 1.2%  
Interest coverage x498.49.8 5,071.2%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.60.4 138.5%   
Return on assets %12.93.6 357.8%  
Return on equity %63.75.6 1,132.2%  
Return on capital %89.54.9 1,814.3%  
Exports to sales %18.00-   
Imports to sales %25.20-   
Net fx Rs m-2,0340-   
CASH FLOW
From Operations Rs m2,304269,772 0.9%  
From Investments Rs m375-95,591 -0.4%  
From Financial Activity Rs m-8,783-323,609 2.7%  
Net Cashflow Rs m-6,104-149,429 4.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare SANOFI INDIA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare SANOFI INDIA With: KREBS BIOCHEMICALS  PROCTER & GAMBLE HEALTH  BACIL PHARMA  INDOCO REMEDIES  NORRIS MEDICINES  



Today's Market

Sensex Today Ends 487 Points Higher | Metal Stocks Shine | SBI & Axis Bank Zoom 5% Sensex Today Ends 487 Points Higher | Metal Stocks Shine | SBI & Axis Bank Zoom 5%(Closing)

After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.